ERB-B4
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ERB-B4, covering 2017-03-13 to 2017-03-13. Get the full timeline:
Most recent: Clinical Trial Update: ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer [EARLY_Phase 1]